Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
3.052
+0.052 (1.73%)
At close: Aug 13, 2025, 4:00 PM
5.97
+2.92 (95.61%)
Pre-market: Aug 14, 2025, 9:25 AM EDT
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 8 employees as of March 31, 2025. The number of employees decreased by 2 or -20.00% compared to the previous year.
Employees
8
Change (1Y)
-2
Growth (1Y)
-20.00%
Revenue / Employee
$1,864,000
Profits / Employee
-$444,375
Market Cap
5.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNOA News
- 17 hours ago - Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains - Accesswire
- 6 days ago - Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - Accesswire
- 4 months ago - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain - Accesswire
- 5 months ago - Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - Accesswire
- 6 months ago - Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - Accesswire
- 6 months ago - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results - Accesswire
- 8 months ago - Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Accesswire